Quality of life as an outcome measure in clinical trials

Bibliografische Angaben

Nachweis in CareLit

Kernaussage aus der Literatur

Abstract-Vorschau

The Quality of Life-Bronchiectasis (QOL-B), is a new, self-administered, patient-reported outcome measure assessing symptoms, functioning and health-related quality of life for patients with non-cystic fibrosis (CF) bronchiectasis. It was developed using the FDA Guidance on Patient-Reported Outcomes (FDA, 2009) and with consultations from the FDA. Thus, it can be used as a primary or secondary endpoint in clinical t…

Zitieren

Zitierempfehlung

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur